Skip to main content
Clinical Trials/NCT01797601
NCT01797601
Completed
Not Applicable

Insulinsensitivität Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin

University Hospital Tuebingen1 site in 1 country48 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Human Insulin
Conditions
Obesity
Sponsor
University Hospital Tuebingen
Enrollment
48
Locations
1
Primary Endpoint
Insulin effect on regional brain activity assessed by fMRI
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of the study is to investigate whether insulin sensitivity and insulin resistance of the human brain is comparable in all insulin sensitive parts of the brain and whether correlates to other phenotypic information (i.e. whole body insulin sensitivity, BMI, age) of the study participants.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
April 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

andreas fritsche

Prof. Andreas Fritsche

University Hospital Tuebingen

Eligibility Criteria

Inclusion Criteria

  • Normal routine blood works
  • for women: negative pregnancy test

Exclusion Criteria

  • Type 2 diabetes
  • pregnancy
  • acute or chronic diseases
  • Pacemakers
  • Artificial heart valves
  • Metal prostheses
  • Implanted magnetic metal parts (screws, ...)
  • Metal fragments
  • insulin pumps
  • claustrophobia

Arms & Interventions

Human Insulin

Nasal spray

Intervention: Human Insulin

Placebo solution

Nasal spray

Intervention: Placebo

Outcomes

Primary Outcomes

Insulin effect on regional brain activity assessed by fMRI

Time Frame: Change from Baseline to 15 minutes and 60 minutes post spray application

Study Sites (1)

Loading locations...

Similar Trials